Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest The UpTake Stories

2012-01-09 07:03:00

TUSTIN, Calif., Jan. 9, 2012 /PRNewswire/ -- Uptake Medical® today announced that it has closed on a Series C funding round. The round was led by Singapore-based Crescent Point Group, with existing investors, Maverick Capital, ONSET Ventures, GBS Venture Partners, WRF Capital, Arboretum Ventures and Affinity Capital, making additional investments. Sami Sindi, Crescent Point managing partner, will join the Uptake Medical board of directors. Moelis & Company acted as...

2011-03-01 07:17:00

IRVINE, Calif., March 1, 2011 /PRNewswire/ -- Uptake Medical® Corp., a developer of medical technologies for the non-surgical treatment of lung diseases including emphysema, announced today that Scott Huennekens, President and CEO of Volcano Corporation, (Nasdaq: VOLC) has joined the company's Board of Directors. Mr. Huennekens has served as President, CEO and Director of Volcano since April 2002. He led the company from a pre-revenue start-up to its IPO in 2006 and its...

2011-02-10 11:00:00

PALO ALTO, Calif., Feb. 10, 2011 /PRNewswire/ -- UpTake Networks, Inc. (owner of RealTravel.com and UpTake.com) is investing to accelerate growth with the addition of Lesley Kao as VP of Product and Chris Hickson as VP of Revenue. Lesley and Chris are based in the UpTake Networks headquarters in Palo Alto, CA and will report to Yen Lee, co-founder and President of UpTake Networks ("UpTake"). Russ Fradin joins as an independent Board member. "I'm delighted to work with Lesley and Chris...

2010-07-07 07:06:00

SEATTLE and IRVINE, Calif., July 7 /PRNewswire/ -- Uptake Medical, a privately held interventional pulmonology company, announced today that it has concluded its Series B financing from an investment group led by Maverick Capital, a new investor. The company plans to use this capital to obtain the CE mark and introduce its unique proprietary Bronchoscopic Thermal Vapor Ablation (BTVA) technology outside of the U.S. The company also has begun its approval cycle with the FDA in the U.S. The...